Qinglin Yu

483 total citations
20 papers, 377 citations indexed

About

Qinglin Yu is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Qinglin Yu has authored 20 papers receiving a total of 377 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 8 papers in Molecular Biology and 6 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Qinglin Yu's work include Antiplatelet Therapy and Cardiovascular Diseases (8 papers), Diabetes Treatment and Management (6 papers) and Platelet Disorders and Treatments (3 papers). Qinglin Yu is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (8 papers), Diabetes Treatment and Management (6 papers) and Platelet Disorders and Treatments (3 papers). Qinglin Yu collaborates with scholars based in China and Russia. Qinglin Yu's co-authors include Yingli Liu, Hongyan Li, Jia Su, Baoguo Sun, Xuetuan Wei, Jing Wang, Xiaohong Chen, Jin Xu, Lindan Ji and Jiyi Li and has published in prestigious journals such as PLoS ONE, Journal of Agricultural and Food Chemistry and Frontiers in Microbiology.

In The Last Decade

Qinglin Yu

19 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qinglin Yu China 12 178 91 69 53 50 20 377
Ching-Yen Lin Taiwan 14 223 1.3× 54 0.6× 41 0.6× 53 1.0× 55 1.1× 25 527
Cynthia Chatterjee Canada 9 243 1.4× 41 0.5× 106 1.5× 69 1.3× 29 0.6× 12 594
Stefan F.C. Vaessen Netherlands 13 154 0.9× 122 1.3× 63 0.9× 103 1.9× 25 0.5× 24 557
Khan Farheen Badrealam India 12 213 1.2× 26 0.3× 45 0.7× 13 0.2× 43 0.9× 25 422
Vatsala Maitin United Kingdom 9 276 1.6× 42 0.5× 219 3.2× 62 1.2× 25 0.5× 22 643
Xiaowei Huo China 13 202 1.1× 41 0.5× 24 0.3× 20 0.4× 24 0.5× 28 462
Hiroshi Kawamata Japan 12 141 0.8× 65 0.7× 40 0.6× 29 0.5× 15 0.3× 15 490
Chengjian Yang China 13 143 0.8× 28 0.3× 37 0.5× 18 0.3× 53 1.1× 21 494
Naief Dahran Saudi Arabia 12 74 0.4× 21 0.2× 67 1.0× 20 0.4× 29 0.6× 46 379

Countries citing papers authored by Qinglin Yu

Since Specialization
Citations

This map shows the geographic impact of Qinglin Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qinglin Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qinglin Yu more than expected).

Fields of papers citing papers by Qinglin Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qinglin Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qinglin Yu. The network helps show where Qinglin Yu may publish in the future.

Co-authorship network of co-authors of Qinglin Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Qinglin Yu. A scholar is included among the top collaborators of Qinglin Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qinglin Yu. Qinglin Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Yu, Qinglin, Zhenwei Li, Jiyi Li, et al.. (2023). Transcriptome-wide map of N6-methyladenosine (m6A) profiling in coronary artery disease (CAD) with clopidogrel resistance. Clinical Epigenetics. 15(1). 194–194. 5 indexed citations
3.
Liu, Yingli, et al.. (2023). Antioxidant effect of yeast on lipid oxidation in salami sausage. Frontiers in Microbiology. 13. 1113848–1113848. 19 indexed citations
4.
Li, Jiyi, et al.. (2022). The DNAm levels of CREB5 (cg11301281) were associated with clopidogrel resistance. Journal of Clinical Laboratory Analysis. 36(10). e24690–e24690. 1 indexed citations
5.
Yu, Qinglin, Jiang Wang, Jiyi Li, et al.. (2022). DNA methylation profile in the whole blood of acute coronary syndrome patients with aspirin resistance. Journal of Clinical Laboratory Analysis. 37(1). e24821–e24821. 2 indexed citations
6.
Su, Jia, Qinglin Yu, Nan Zheng, et al.. (2021). The association of polymorphisms in related circadian rhythm genes and clopidogrel resistance susceptibility. Basic & Clinical Pharmacology & Toxicology. 129(3). 196–209. 2 indexed citations
7.
Lv, Mingfa, Yufan Chen, Ming Hu, et al.. (2021). OhrR is a central transcriptional regulator of virulence in Dickeya zeae. Molecular Plant Pathology. 23(1). 45–59. 14 indexed citations
8.
Yuan, Juanli, Qinglin Yu, Huijia Mao, et al.. (2021). Celiac Disease and Immunogenic Wheat Gluten Peptides and the Association of Gliadin Peptides with HLA DQ2 and HLA DQ8. Food Reviews International. 38(7). 1553–1576. 11 indexed citations
9.
Yu, Qinglin, Nan Zheng, Jiyi Li, et al.. (2021). Clopidogrel Resistance Is Associated With DNA Methylation of Genes From Whole Blood of Humans. Frontiers in Genetics. 11. 583215–583215. 12 indexed citations
10.
Liu, Yingli, et al.. (2021). Functional Characteristics of Lactobacillus and Yeast Single Starter Cultures in the Ripening Process of Dry Fermented Sausage. Frontiers in Microbiology. 11. 611260–611260. 35 indexed citations
11.
Zheng, Nan, et al.. (2021). Associations of PER3 polymorphisms with clopidogrel resistance among Chinese Han people treated with clopidogrel. Journal of Clinical Laboratory Analysis. 35(4). e23713–e23713. 4 indexed citations
12.
Yu, Qinglin, et al.. (2021). Gene polymorphisms of insulin secretion signaling pathway associated with clopidogrel resistance in Han Chinese population. Journal of Clinical Laboratory Analysis. 35(11). e23970–e23970. 4 indexed citations
13.
Yu, Qinglin, Hongyan Li, Xuetuan Wei, et al.. (2020). Prebiotic, Probiotic, Antimicrobial, and Functional Food Applications of Bacillus amyloliquefaciens. Journal of Agricultural and Food Chemistry. 68(50). 14709–14727. 93 indexed citations
14.
Su, Jia, Jiyi Li, Qinglin Yu, et al.. (2019). Exosomal miRNAs as potential biomarkers for acute myocardial infarction. IUBMB Life. 72(3). 384–400. 47 indexed citations
15.
Yu, Qinglin, et al.. (2019). The effect of Xuefu Zhuyu decoction on clopidogrel resistance and its association with the P2Y12 Gene polymorphisms and promoter DNA methylation.. PubMed. 32(6). 2565–2572. 3 indexed citations
16.
Su, Jia, Jiyi Li, Qinglin Yu, et al.. (2019). Association of PON1 gene promoter DNA methylation with the risk of Clopidogrel resistance in patients with coronary artery disease. Journal of Clinical Laboratory Analysis. 33(5). e22867–e22867. 20 indexed citations
17.
Yu, Qinglin, et al.. (2018). Exploring succinic acid production by engineered Yarrowia lipolytica strains using glucose at low pH. Biochemical Engineering Journal. 139. 51–56. 29 indexed citations
18.
Su, Jia, Qinglin Yu, Hao Zhu, et al.. (2017). The risk of clopidogrel resistance is associated with ABCB1 polymorphisms but not promoter methylation in a Chinese Han population. PLoS ONE. 12(3). e0174511–e0174511. 19 indexed citations
19.
Su, Jia, Jin Xu, Jun Yang, et al.. (2015). ABCB1 C3435T polymorphism and the lipid-lowering response in hypercholesterolemic patients on statins: a meta-analysis. Lipids in Health and Disease. 14(1). 122–122. 29 indexed citations
20.
Su, Jia, Xiaojing Li, Qinglin Yu, et al.. (2014). Association ofP2Y12Gene Promoter DNA Methylation with the Risk of Clopidogrel Resistance in Coronary Artery Disease Patients. BioMed Research International. 2014. 1–8. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ching-Yen Lin Breakdown of academic impact, for papers by Cynthia Chatterjee Breakdown of academic impact, for papers by Stefan F.C. Vaessen Breakdown of academic impact, for papers by Khan Farheen Badrealam Breakdown of academic impact, for papers by Vatsala Maitin Breakdown of academic impact, for papers by Xiaowei Huo Breakdown of academic impact, for papers by Hiroshi Kawamata Breakdown of academic impact, for papers by Chengjian Yang Breakdown of academic impact, for papers by Naief Dahran
Rankless by CCL
2026